hydroxychloroquine and nirmatrelvir

hydroxychloroquine has been researched along with nirmatrelvir in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Barbosa, AN; Bernardo, WM; Chebabo, A; Cimerman, S; Croda, J; Cunha, CA; de Luna, D; Falavigna, M; Ferreira, JC; Gomes-da-Silva, MM; Nunes, EP; Parahiba, SM; Pérez, C; Rodriguez-Morales, AJ; Starling, C; Tanni, S; Thormann, M; Zambrano, G	1

Reviews

1 review(s) available for hydroxychloroquine and nirmatrelvir

Article	Year
Pan-American Guidelines for the treatment of SARS-CoV-2/COVID-19: a joint evidence-based guideline of the Brazilian Society of Infectious Diseases (SBI) and the Pan-American Association of Infectious Diseases (API). Annals of clinical microbiology and antimicrobials, 2023, Aug-07, Volume: 22, Issue:1 Topics: Antiviral Agents; Brazil; Communicable Diseases; COVID-19; Humans; Hydroxychloroquine; Ivermectin; Pandemics; Ritonavir; SARS-CoV-2; United States	2023

Article

Year

Pan-American Guidelines for the treatment of SARS-CoV-2/COVID-19: a joint evidence-based guideline of the Brazilian Society of Infectious Diseases (SBI) and the Pan-American Association of Infectious Diseases (API).

Annals of clinical microbiology and antimicrobials, 2023, Aug-07, Volume: 22, Issue:1

Topics: Antiviral Agents; Brazil; Communicable Diseases; COVID-19; Humans; Hydroxychloroquine; Ivermectin; Pandemics; Ritonavir; SARS-CoV-2; United States

2023